Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Schellenberg

Showing results (81-90 of 97) with videos related to

Pageof 10
Sort By:
Lancet (London, England)|November 3, 2004
Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in TanzaniaJoanna R M Armstrong Schellenberg, Taghreed Adam, Hassan Mshinda, et al.
Malaria Journal|August 6, 2011
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient careJohan Vekemans, Kevin Marsh, Brian Greenwood, et al.
Plos One|May 29, 2015
Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, NigeriaHarparkash Kaur, Elizabeth Louise Allan, Ibrahim Mamadu, et al.
The American Journal of Tropical Medicine and Hygiene|December 20, 2023
Development of WHO Recommendations for the Final Phase of Elimination and Prevention of Re-Establishment of MalariaKevin Marsh, Elie Akl, Jane Achan, et al.
Malaria Journal|January 10, 2013
Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic regionSalim Abdulla, Nahya Salim, Francisca Machera, et al.
Plos Medicine|May 9, 2024
Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodologyAndria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, et al.
Implementation Science : IS|June 18, 2014
The practice of 'doing' evaluation: lessons learned from nine complex intervention trials in actionJoanna Reynolds, Deborah DiLiberto, Lindsay Mangham-Jefferies, et al.
Plos One|June 19, 2010
The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaLesong Conteh, Elisa Sicuri, Fatuma Manzi, et al.
Lancet (London, England)|April 7, 2024
Feasibility, safety, and impact of the RTS,S/AS01<sub>E</sub> malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and MalawiKwaku Poku Asante, Don P Mathanga, Paul Milligan, et al.
Lancet (London, England)|September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trialsJohn J Aponte, David Schellenberg, Andrea Egan, et al.
Pageof 10

Showing results (81-90 of 97) with videos related to

Sort By:
Pageof 10
Lancet (London, England)|November 3, 2004
Effectiveness and cost of facility-based Integrated Management of Childhood Illness (IMCI) in TanzaniaJoanna R M Armstrong Schellenberg, Taghreed Adam, Hassan Mshinda, et al.
Malaria Journal|August 6, 2011
Assessment of severe malaria in a multicenter, phase III, RTS, S/AS01 malaria candidate vaccine trial: case definition, standardization of data collection and patient careJohan Vekemans, Kevin Marsh, Brian Greenwood, et al.
Plos One|May 29, 2015
Quality of artemisinin-based combination formulations for malaria treatment: prevalence and risk factors for poor quality medicines in public facilities and private sector drug outlets in Enugu, NigeriaHarparkash Kaur, Elizabeth Louise Allan, Ibrahim Mamadu, et al.
The American Journal of Tropical Medicine and Hygiene|December 20, 2023
Development of WHO Recommendations for the Final Phase of Elimination and Prevention of Re-Establishment of MalariaKevin Marsh, Elie Akl, Jane Achan, et al.
Malaria Journal|January 10, 2013
Randomized, controlled trial of the long term safety, immunogenicity and efficacy of RTS,S/AS02(D) malaria vaccine in infants living in a malaria-endemic regionSalim Abdulla, Nahya Salim, Francisca Machera, et al.
Plos Medicine|May 9, 2024
Measuring protective efficacy and quantifying the impact of drug resistance: A novel malaria chemoprevention trial design and methodologyAndria Mousa, Gina Cuomo-Dannenburg, Hayley A Thompson, et al.
Implementation Science : IS|June 18, 2014
The practice of 'doing' evaluation: lessons learned from nine complex intervention trials in actionJoanna Reynolds, Deborah DiLiberto, Lindsay Mangham-Jefferies, et al.
Plos One|June 19, 2010
The cost-effectiveness of intermittent preventive treatment for malaria in infants in Sub-Saharan AfricaLesong Conteh, Elisa Sicuri, Fatuma Manzi, et al.
Lancet (London, England)|April 7, 2024
Feasibility, safety, and impact of the RTS,S/AS01<sub>E</sub> malaria vaccine when implemented through national immunisation programmes: evaluation of cluster-randomised introduction of the vaccine in Ghana, Kenya, and MalawiKwaku Poku Asante, Don P Mathanga, Paul Milligan, et al.
Lancet (London, England)|September 22, 2009
Efficacy and safety of intermittent preventive treatment with sulfadoxine-pyrimethamine for malaria in African infants: a pooled analysis of six randomised, placebo-controlled trialsJohn J Aponte, David Schellenberg, Andrea Egan, et al.
Pageof 10